Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma.
Journal: The New England journal of medicine
Published: July 15, 2026
Linvoseltamab versus elranatamab for triple-class exposed relapsed or refractory multiple myeloma: an indirect treatment comparison.
Journal: Leukemia & lymphoma
Published: July 10, 2026
What's liver got to do with it? Hepatic response and survival in AL amyloidosis.
Journal: Haematologica
Published: July 06, 2026
A systematic review of indirect treatment comparisons among recently approved chimeric antigen receptor T-cell and bispecific antibody therapies for triple-class exposed relapsed/refractory multiple myeloma.
Journal: Current medical research and opinion
Published: June 25, 2026
Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020.
Journal: Bone marrow transplantation
Published: December 18, 2025
Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial.
Journal: The Lancet. Haematology
Published: November 21, 2025
Diagnostic Journeys and Delays in AL Amyloidosis: Insights From a Cross-Sectional Patient Survey.
Journal: Clinical lymphoma, myeloma & leukemia
Published: November 10, 2025
Last Updated: 09/26/2026